longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

CHINA REFORM HEALTH

000503

----
Start trading
OverviewOverviewNewsNewsPostsPostsFinancialsFinancialsForecastForecastValuationValuationShareholdersShareholdersProfileProfile
LongbridgeAI

Q2 2026 Earnings

Financial report interval: 2026.03.30 - 2026.06.30

Overview: CHINA REFORM HEALTH(000503) the Revenue is 51.02 M (+13.23%);the EBIT is -49.9 M (+14.86%);the EPS is -0.0547 (+0.03%).

Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.05B13.23%
----
----
EBIT
-0.05B14.86%
----
----
EPS
-0.05470.03%
----
----

Revenue

ActualEstimateUnit: CNY
qf

EBIT

ActualEstimateUnit: CNY
qf

Net income

ActualEstimateUnit: CNY
qf

EPS

ActualEstimateUnit: CNY
qf